羟基磷灰石义眼台置入术的临床效果观察  

Clinical effect of hydroxyapatite orbital implantation

作　　者：王健[1] 解正高[1] 陈放[1] 叶东升[1] 

机构地区：[1]江苏省苏北人民医院眼科,江苏扬州225001

出　　处：《中国美容医学》2012年第07X期117-118,共2页Chinese Journal of Aesthetic Medicine

摘　　要：目的:探讨羟基磷灰石(hydroxyapatite,HA)义眼台置入术的方法和临床疗效。方法:对37例病例资料进行回顾性分析,所有病例全部采用自体巩膜包裹义眼台置入方法,术后随访6～24个月,观察术后效果。结果:37例病例发生义眼台暴露1例,无HA义眼台排斥、感染、脱出、移位;无眶内感染及上睑下垂现象。结论:羟基磷灰石义眼台置入术的最严重并发症义眼台暴露,其原因较多,但主要与手术方式关系最为密切,我们认为最好采取自体巩膜包裹的Ⅰ期置入方式。Objective To investigate the operation methods and clinical effects of hydroxyapatite （HA） orbital implantation. Methods We retrospectively analyzed the documents of 37 cases treated with autogeneic sclera encapsulation. The following up time was 6 months to years. Results Exposure associated with orbital hydroxyapatite implants was presented in only 1 cases. There were no postoperative complications such as exclusion, infection, prolapsus, and so on. No orbital infection and ptosis occured. Conclusion The common complication of orbital Hydroxyapatite implants is exposure which has close relationship with operation method.We believe autogeneicsciera encapsulation is the best method.

关 键 词：羟基磷灰石义眼台 义眼台置入术 

分 类 号：R779.64[医药卫生—眼科]